Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03045484
What this trial is testing

Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 70
Not applicableStudy completedNCT00809016
What this trial is testing

PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 40
Testing effectiveness (Phase 2)UnknownNCT02915432
What this trial is testing

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

Who this might be right for
Gastric AdenocarcinomaEsophageal Squamous Cell CarcinomaNasopharyngeal Carcinoma+1 more
Shanghai Junshi Bioscience Co., Ltd. 401
Not applicableLooking for participantsNCT06307314
What this trial is testing

Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis

Who this might be right for
Nasopharyngeal CarcinomaHead and Neck CancerRadiotherapy-induced Oral Mucositis+1 more
Nanfang Hospital, Southern Medical University 300
Large-scale testing (Phase 3)Looking for participantsNCT06563479
What this trial is testing

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 291
Large-scale testing (Phase 3)UnknownNCT06486220
What this trial is testing

PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.

Who this might be right for
Nasopharyngeal Carcinoma
Yun-fei Xia 96
Testing effectiveness (Phase 2)Study completedNCT04528394
What this trial is testing

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 136
Not applicableUnknownNCT04472403
What this trial is testing

Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaMetastasisChemotherapy+1 more
Sun Yat-sen University 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Study completedNCT03175939
What this trial is testing

Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer
Sun Yat-sen University 263
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Not applicableUnknownNCT05037357
What this trial is testing

Verification of Harmonization of Plasma Epstein-Barr Virus DNA Measurements

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 370
Testing effectiveness (Phase 2)Study completedNCT04220307
What this trial is testing

A PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 34
Testing effectiveness (Phase 2)UnknownNCT04917770
What this trial is testing

The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
West China Hospital 28
Testing effectiveness (Phase 2)UnknownNCT04627961
What this trial is testing

A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal Carcinoma
National University Hospital, Singapore 33
Testing effectiveness (Phase 2)UnknownNCT03130270
What this trial is testing

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guilin Medical University, China 29
Large-scale testing (Phase 3)UnknownNCT05519956
What this trial is testing

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 398
Post-approval studies (Phase 4)Looking for participantsNCT06457503
What this trial is testing

Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer Recurrent
Coherus Oncology, Inc. 100
Not applicableStudy completedNCT04489212
What this trial is testing

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+3 more
Mayo Clinic
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Next Page
2